Recall Record

Schaumburg, IL, United States

Sagent Pharmaceuticals Inc recalls

9 recalls recorded since 2018, most recently on 4 May 2026. 5 are listed as ongoing. Status and classification are as published by the FDA.

Recalls9
Ongoing (FDA)5
Terminated or completed4
Class I (FDA)1

Ongoing Class III Drugs

Recall started
4 May 2026
Reason
Failed Impurities/Degradation Specifications
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall number
D-0539-2026

Ongoing Class I Drugs

Recall started
28 May 2024
Reason
Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.
Distribution
Nationwide within the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0554-2024, D-0553-2024

Ongoing Class II Drugs

Recall started
25 April 2024
Reason
Presence of Particulate Matter: Potential for black particulates in the drug product.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0499-2024

Ongoing Class II Drugs

Recall started
11 July 2023
Reason
Lack of Assurance of Sterility
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0935-2023, D-0936-2023, D-0937-2023

Ongoing Class II Drugs

Recall started
19 May 2023
Reason
Lack of Assurance of Sterility
Distribution
Nationwide USA
Initiated
Voluntary: Firm initiated
Recall numbers
D-0764-2023, D-0763-2023, D-0762-2023

Terminated Class II Drugs

Recall started
28 February 2023
Terminated
19 May 2026
Reason
Labeling: Not elsewhere classified
Distribution
USA Nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0435-2023

Terminated Class II Drugs

Recall started
11 March 2021
Terminated
28 December 2022
Reason
Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.
Distribution
Nationwide in the USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-0305-2021

Terminated Class II Drugs

Recall started
30 April 2019
Terminated
28 September 2020
Reason
Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Distribution
Nationwide USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-1274-2019

Terminated Class II Drugs

Recall started
5 March 2018
Terminated
15 April 2020
Reason
Failed Impurities/Degradation Specifications: High out of specification results for an impurity.
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0586-2018, D-0588-2018, D-0587-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.